Clinical Trial Update: Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin as add-on or monotherapy for aging individuals with multiple sclerosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Multiple Sclerosis | Phase 2 | Status: RECRUITING